IL299622A - A pharmaceutical composition containing a growth receptor agonist and an adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and its uses - Google Patents

Info

Publication number

IL299622A

IL299622A IL299622A IL29962223A IL299622A IL 299622 A IL299622 A IL 299622A IL 299622 A IL299622 A IL 299622A IL 29962223 A IL29962223 A IL 29962223A IL 299622 A IL299622 A IL 299622A

Authority

IL

Israel

Prior art keywords

peptide

amino acids

glu

lys

val

Prior art date

2015-09-17

Links

• Espacenet
• Global Dossier
• Discuss

• 210000005170 neoplastic cell Anatomy 0.000 title claims description 114
• 239000012268 protein inhibitor Substances 0.000 title claims description 24
• 229940121649 protein inhibitor Drugs 0.000 title claims description 24
• 229940124108 Growth factor receptor agonist Drugs 0.000 title 1
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 448
• 150000001413 amino acids Chemical class 0.000 claims description 441
• 241000711981 Sais Species 0.000 claims description 381
• 102000009465 Growth Factor Receptors Human genes 0.000 claims description 314
• 108010009202 Growth Factor Receptors Proteins 0.000 claims description 314
• 230000027455 binding Effects 0.000 claims description 313
• 150000001875 compounds Chemical class 0.000 claims description 298
• 239000000816 peptidomimetic Substances 0.000 claims description 78
• 108090000623 proteins and genes Proteins 0.000 claims description 71
• 238000000034 method Methods 0.000 claims description 68
• 102000004169 proteins and genes Human genes 0.000 claims description 52
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 50
• 201000010099 disease Diseases 0.000 claims description 47
• 230000001613 neoplastic effect Effects 0.000 claims description 45
• 238000011282 treatment Methods 0.000 claims description 33
• 101000701051 Legionella pneumophila Zinc metalloproteinase Proteins 0.000 claims description 28
• 239000000203 mixture Substances 0.000 claims description 24
• 108050006774 Syndecan Proteins 0.000 claims description 18
• 125000004122 cyclic group Chemical group 0.000 claims description 14
• 102000019361 Syndecan Human genes 0.000 claims description 13
• 102000001301 EGF receptor Human genes 0.000 claims description 10
• 108060006698 EGF receptor Proteins 0.000 claims description 10
• 102000006495 integrins Human genes 0.000 claims description 10
• 108010044426 integrins Proteins 0.000 claims description 10
• 102000005962 receptors Human genes 0.000 claims description 10
• 108020003175 receptors Proteins 0.000 claims description 10
• 238000000338 in vitro Methods 0.000 claims description 9
• 102000004584 Somatomedin Receptors Human genes 0.000 claims description 8
• 108010017622 Somatomedin Receptors Proteins 0.000 claims description 8
• 108010069514 Cyclic Peptides Proteins 0.000 claims description 6
• 102000001189 Cyclic Peptides Human genes 0.000 claims description 6
• 230000021164 cell adhesion Effects 0.000 claims description 6
• 239000003112 inhibitor Substances 0.000 claims description 6
• DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims description 6
• 108091008794 FGF receptors Proteins 0.000 claims description 5
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 claims description 5
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 claims description 5
• 102000007339 Nerve Growth Factor Receptors Human genes 0.000 claims description 5
• 108091008606 PDGF receptors Proteins 0.000 claims description 5
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 claims description 5
• 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 claims description 5
• 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 claims description 5
• 108091008605 VEGF receptors Proteins 0.000 claims description 5
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims description 5
• 230000002265 prevention Effects 0.000 claims description 4
• 102000007623 Dystroglycans Human genes 0.000 claims description 3
• 108010071885 Dystroglycans Proteins 0.000 claims description 3
• 102000003800 Selectins Human genes 0.000 claims description 3
• 108090000184 Selectins Proteins 0.000 claims description 3
• 108010043648 Discoidin Domain Receptors Proteins 0.000 claims description 2
• 102000002706 Discoidin Domain Receptors Human genes 0.000 claims description 2
• 108091008815 Eph receptors Proteins 0.000 claims description 2
• 101001004623 Homo sapiens Lactase-like protein Proteins 0.000 claims description 2
• 108010001127 Insulin Receptor Proteins 0.000 claims description 2
• 102000003746 Insulin Receptor Human genes 0.000 claims description 2
• 108091008555 LTK receptors Proteins 0.000 claims description 2
• 102100025640 Lactase-like protein Human genes 0.000 claims description 2
• 108091008553 MuSK receptors Proteins 0.000 claims description 2
• 108091008551 RET receptors Proteins 0.000 claims description 2
• 108091008554 ROR receptors Proteins 0.000 claims description 2
• 108091008552 RYK receptors Proteins 0.000 claims description 2
• 101100517381 Rattus norvegicus Ntrk1 gene Proteins 0.000 claims description 2
• 102000005450 TIE receptors Human genes 0.000 claims description 2
• 108010006830 TIE receptors Proteins 0.000 claims description 2
• 102100037236 Tyrosine-protein kinase receptor UFO Human genes 0.000 claims description 2
• 101100189913 Caenorhabditis elegans pept-1 gene Proteins 0.000 claims 2
• 108010088535 Pep-1 peptide Proteins 0.000 claims 2
• 230000009646 cyclic growth Effects 0.000 claims 2
• AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 claims 2
• 108010085004 TGF-beta Superfamily Proteins Proteins 0.000 claims 1
• 102000007453 TGF-beta Superfamily Proteins Human genes 0.000 claims 1
• 229940125798 integrin inhibitor Drugs 0.000 claims 1
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 238000012216 screening Methods 0.000 claims 1
• 235000001014 amino acid Nutrition 0.000 description 443
• 229940024606 amino acid Drugs 0.000 description 443
• 210000004027 cell Anatomy 0.000 description 236
• 230000008094 contradictory effect Effects 0.000 description 117
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 98
• 206010028980 Neoplasm Diseases 0.000 description 74
• 102000004196 processed proteins & peptides Human genes 0.000 description 72
• 235000018102 proteins Nutrition 0.000 description 46
• 230000014509 gene expression Effects 0.000 description 44
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 36
• 210000001519 tissue Anatomy 0.000 description 36
• 201000011510 cancer Diseases 0.000 description 34
• 239000000126 substance Substances 0.000 description 34
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 28
• 238000002560 therapeutic procedure Methods 0.000 description 26
• 238000011161 development Methods 0.000 description 25
• 230000018109 developmental process Effects 0.000 description 25
• 239000012071 phase Substances 0.000 description 24
• 230000003993 interaction Effects 0.000 description 23
• 229920001184 polypeptide Polymers 0.000 description 23
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 22
• 230000022131 cell cycle Effects 0.000 description 22
• 210000000130 stem cell Anatomy 0.000 description 22
• 108090000259 Cyclin D Proteins 0.000 description 21
• 239000002243 precursor Substances 0.000 description 21
• -1 2-pentyl Chemical group 0.000 description 20
• 102000003910 Cyclin D Human genes 0.000 description 20
• 239000000427 antigen Substances 0.000 description 19
• 108091007433 antigens Proteins 0.000 description 19
• 102000036639 antigens Human genes 0.000 description 19
• 230000004069 differentiation Effects 0.000 description 19
• 230000006870 function Effects 0.000 description 18
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 17
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 17
• 210000000056 organ Anatomy 0.000 description 17
• 230000002829 reductive effect Effects 0.000 description 17
• 229910052740 iodine Inorganic materials 0.000 description 16
• 230000001105 regulatory effect Effects 0.000 description 16
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 15
• 230000032823 cell division Effects 0.000 description 15
• 108020004414 DNA Proteins 0.000 description 14
• 210000004369 blood Anatomy 0.000 description 14
• 239000008280 blood Substances 0.000 description 14
• 230000000694 effects Effects 0.000 description 14
• 230000001939 inductive effect Effects 0.000 description 14
• 230000003834 intracellular effect Effects 0.000 description 14
• 229920000642 polymer Polymers 0.000 description 14
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 13
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 13
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 13
• 241001465754 Metazoa Species 0.000 description 13
• 230000015572 biosynthetic process Effects 0.000 description 13
• 210000000963 osteoblast Anatomy 0.000 description 13
• 230000008569 process Effects 0.000 description 13
• 125000004429 atom Chemical group 0.000 description 12
• CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 11
• 210000000601 blood cell Anatomy 0.000 description 11
• 210000004899 c-terminal region Anatomy 0.000 description 11
• 238000006243 chemical reaction Methods 0.000 description 11
• 239000003102 growth factor Substances 0.000 description 11
• 230000035755 proliferation Effects 0.000 description 11
• 102000016736 Cyclin Human genes 0.000 description 10
• 108050006400 Cyclin Proteins 0.000 description 10
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 10
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 10
• 238000011529 RT qPCR Methods 0.000 description 10
• 210000001789 adipocyte Anatomy 0.000 description 10
• 238000004458 analytical method Methods 0.000 description 10
• 230000004071 biological effect Effects 0.000 description 10
• 230000004663 cell proliferation Effects 0.000 description 10
• 201000008968 osteosarcoma Diseases 0.000 description 10
• 229910052698 phosphorus Inorganic materials 0.000 description 10
• 238000011084 recovery Methods 0.000 description 10
• 210000003491 skin Anatomy 0.000 description 10
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 9
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 9
• 230000003213 activating effect Effects 0.000 description 9
• 238000000198 fluorescence anisotropy Methods 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 210000001178 neural stem cell Anatomy 0.000 description 9
• 230000026731 phosphorylation Effects 0.000 description 9
• 238000006366 phosphorylation reaction Methods 0.000 description 9
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 8
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 8
• 230000002159 abnormal effect Effects 0.000 description 8
• 210000000988 bone and bone Anatomy 0.000 description 8
• 210000001185 bone marrow Anatomy 0.000 description 8
• 229910052799 carbon Inorganic materials 0.000 description 8
• 210000002950 fibroblast Anatomy 0.000 description 8
• 230000012010 growth Effects 0.000 description 8
• 210000004072 lung Anatomy 0.000 description 8
• 210000003205 muscle Anatomy 0.000 description 8
• 210000002569 neuron Anatomy 0.000 description 8
• 230000001737 promoting effect Effects 0.000 description 8
• 238000001262 western blot Methods 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
• IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 7
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 7
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 7
• 108091007914 CDKs Proteins 0.000 description 7
• 230000010190 G1 phase Effects 0.000 description 7
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 7
• 230000018199 S phase Effects 0.000 description 7
• 230000004913 activation Effects 0.000 description 7
• 125000000217 alkyl group Chemical group 0.000 description 7
• 229940112869 bone morphogenetic protein Drugs 0.000 description 7
• 210000001612 chondrocyte Anatomy 0.000 description 7
• 210000002889 endothelial cell Anatomy 0.000 description 7
• 210000004602 germ cell Anatomy 0.000 description 7
• 230000003211 malignant effect Effects 0.000 description 7
• 238000004519 manufacturing process Methods 0.000 description 7
• 229910052717 sulfur Inorganic materials 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
• 201000009030 Carcinoma Diseases 0.000 description 6
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 6
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 6
• 206010025323 Lymphomas Diseases 0.000 description 6
• 102100035721 Syndecan-1 Human genes 0.000 description 6
• 210000001744 T-lymphocyte Anatomy 0.000 description 6
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 6
• 210000000577 adipose tissue Anatomy 0.000 description 6
• 125000000539 amino acid group Chemical group 0.000 description 6
• 230000006907 apoptotic process Effects 0.000 description 6
• 230000006378 damage Effects 0.000 description 6
• 239000000412 dendrimer Substances 0.000 description 6
• 229920000736 dendritic polymer Polymers 0.000 description 6
• 230000002496 gastric effect Effects 0.000 description 6
• 201000005202 lung cancer Diseases 0.000 description 6
• 208000020816 lung neoplasm Diseases 0.000 description 6
• 230000011278 mitosis Effects 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 230000033458 reproduction Effects 0.000 description 6
• 230000022379 skeletal muscle tissue development Effects 0.000 description 6
• 230000009870 specific binding Effects 0.000 description 6
• 210000002435 tendon Anatomy 0.000 description 6
• 230000002792 vascular Effects 0.000 description 6
• 206010003571 Astrocytoma Diseases 0.000 description 5
• 241000196324 Embryophyta Species 0.000 description 5
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 5
• 206010039491 Sarcoma Diseases 0.000 description 5
• 208000000453 Skin Neoplasms Diseases 0.000 description 5
• 101800000936 Structural peptide 4 Proteins 0.000 description 5
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 5
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 5
• 102100028290 Vacuolar protein sorting-associated protein 29 Human genes 0.000 description 5
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
• 230000002378 acidificating effect Effects 0.000 description 5
• 230000009471 action Effects 0.000 description 5
• 210000004504 adult stem cell Anatomy 0.000 description 5
• 125000003275 alpha amino acid group Chemical group 0.000 description 5
• 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 5
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 238000010586 diagram Methods 0.000 description 5
• 210000002919 epithelial cell Anatomy 0.000 description 5
• 210000003743 erythrocyte Anatomy 0.000 description 5
• 229940126864 fibroblast growth factor Drugs 0.000 description 5
• 239000012634 fragment Substances 0.000 description 5
• 125000000524 functional group Chemical group 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 201000010536 head and neck cancer Diseases 0.000 description 5
• 208000014829 head and neck neoplasm Diseases 0.000 description 5
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 5
• 210000003734 kidney Anatomy 0.000 description 5
• 208000032839 leukemia Diseases 0.000 description 5
• 239000003226 mitogen Substances 0.000 description 5
• 108020004707 nucleic acids Proteins 0.000 description 5
• 102000039446 nucleic acids Human genes 0.000 description 5
• 150000007523 nucleic acids Chemical class 0.000 description 5
• 210000004409 osteocyte Anatomy 0.000 description 5
• 229910052760 oxygen Inorganic materials 0.000 description 5
• 239000001301 oxygen Substances 0.000 description 5
• 238000010647 peptide synthesis reaction Methods 0.000 description 5
• 210000002381 plasma Anatomy 0.000 description 5
• 210000000229 preadipocyte Anatomy 0.000 description 5
• 238000011002 quantification Methods 0.000 description 5
• 238000003753 real-time PCR Methods 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 201000000849 skin cancer Diseases 0.000 description 5
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
• 239000013598 vector Substances 0.000 description 5
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 4
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 4
• 206010006187 Breast cancer Diseases 0.000 description 4
• 208000026310 Breast neoplasm Diseases 0.000 description 4
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 4
• 208000005243 Chondrosarcoma Diseases 0.000 description 4
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
• 230000010337 G2 phase Effects 0.000 description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
• 108060003951 Immunoglobulin Proteins 0.000 description 4
• 206010024612 Lipoma Diseases 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 4
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 4
• 201000000582 Retinoblastoma Diseases 0.000 description 4
• 108010009583 Transforming Growth Factors Proteins 0.000 description 4
• 102000009618 Transforming Growth Factors Human genes 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 230000033115 angiogenesis Effects 0.000 description 4
• 230000003443 anti-oncogenic effect Effects 0.000 description 4
• 238000004422 calculation algorithm Methods 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 235000014633 carbohydrates Nutrition 0.000 description 4
• 210000000845 cartilage Anatomy 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 238000002512 chemotherapy Methods 0.000 description 4
• 210000000349 chromosome Anatomy 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 210000002808 connective tissue Anatomy 0.000 description 4
• 239000003814 drug Substances 0.000 description 4
• 239000012039 electrophile Substances 0.000 description 4
• 230000013020 embryo development Effects 0.000 description 4
• 230000002708 enhancing effect Effects 0.000 description 4
• 210000002744 extracellular matrix Anatomy 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 102000018358 immunoglobulin Human genes 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• 230000016507 interphase Effects 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 210000003041 ligament Anatomy 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 210000005265 lung cell Anatomy 0.000 description 4
• 210000004962 mammalian cell Anatomy 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 201000001441 melanoma Diseases 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 238000000329 molecular dynamics simulation Methods 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 239000012038 nucleophile Substances 0.000 description 4
• 210000004940 nucleus Anatomy 0.000 description 4
• 235000015097 nutrients Nutrition 0.000 description 4
• 239000008194 pharmaceutical composition Substances 0.000 description 4
• 230000002062 proliferating effect Effects 0.000 description 4
• 238000001959 radiotherapy Methods 0.000 description 4
• 210000001525 retina Anatomy 0.000 description 4
• 210000001057 smooth muscle myoblast Anatomy 0.000 description 4
• 241000894007 species Species 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 230000032258 transport Effects 0.000 description 4
• 238000010200 validation analysis Methods 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 3
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 3
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 3
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
• 108010058546 Cyclin D1 Proteins 0.000 description 3
• 108010058544 Cyclin D2 Proteins 0.000 description 3
• 108010058545 Cyclin D3 Proteins 0.000 description 3
• 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 3
• 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 3
• 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 3
• 208000017604 Hodgkin disease Diseases 0.000 description 3
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 3
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
• 208000007766 Kaposi sarcoma Diseases 0.000 description 3
• 230000027311 M phase Effects 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 3
• 206010029260 Neuroblastoma Diseases 0.000 description 3
• 102000043276 Oncogene Human genes 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 3
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 3
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 101100385011 Rhizobium leguminosarum bv. viciae (strain 3841) ctaB gene Proteins 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 210000000648 angioblast Anatomy 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000031018 biological processes and functions Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 210000001772 blood platelet Anatomy 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 210000000481 breast Anatomy 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 239000001569 carbon dioxide Substances 0.000 description 3
• 229910002092 carbon dioxide Inorganic materials 0.000 description 3
• 230000003915 cell function Effects 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 229960005395 cetuximab Drugs 0.000 description 3
• 208000024207 chronic leukemia Diseases 0.000 description 3
• 210000001072 colon Anatomy 0.000 description 3
• 210000002249 digestive system Anatomy 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 210000003981 ectoderm Anatomy 0.000 description 3
• 210000003890 endocrine cell Anatomy 0.000 description 3
• 210000002615 epidermis Anatomy 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 210000001650 focal adhesion Anatomy 0.000 description 3
• 239000007789 gas Substances 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 230000030279 gene silencing Effects 0.000 description 3
• 150000004676 glycans Chemical class 0.000 description 3
• 210000005260 human cell Anatomy 0.000 description 3
• 229930195733 hydrocarbon Natural products 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• 238000012744 immunostaining Methods 0.000 description 3
• 230000008676 import Effects 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 230000002147 killing effect Effects 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 210000003716 mesoderm Anatomy 0.000 description 3
• 206010061289 metastatic neoplasm Diseases 0.000 description 3
• 210000003632 microfilament Anatomy 0.000 description 3
• 210000000214 mouth Anatomy 0.000 description 3
• 210000000663 muscle cell Anatomy 0.000 description 3
• 210000004498 neuroglial cell Anatomy 0.000 description 3
• 230000002352 nonmutagenic effect Effects 0.000 description 3
• 239000002777 nucleoside Substances 0.000 description 3
• 150000003833 nucleoside derivatives Chemical class 0.000 description 3
• 230000007170 pathology Effects 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 229920001282 polysaccharide Polymers 0.000 description 3
• 239000005017 polysaccharide Substances 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 230000005855 radiation Effects 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 230000000284 resting effect Effects 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 230000002207 retinal effect Effects 0.000 description 3
• 229920002477 rna polymer Polymers 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 238000002864 sequence alignment Methods 0.000 description 3
• 235000004400 serine Nutrition 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 210000002027 skeletal muscle Anatomy 0.000 description 3
• 206010041823 squamous cell carcinoma Diseases 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• 239000000225 tumor suppressor protein Substances 0.000 description 3
• 210000005167 vascular cell Anatomy 0.000 description 3
• 230000004862 vasculogenesis Effects 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• HEZMWWAKWCSUCB-PHDIDXHHSA-N (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1O HEZMWWAKWCSUCB-PHDIDXHHSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 206010000830 Acute leukaemia Diseases 0.000 description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
• 201000003076 Angiosarcoma Diseases 0.000 description 2
• 206010065869 Astrocytoma, low grade Diseases 0.000 description 2
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 101000715943 Caenorhabditis elegans Cyclin-dependent kinase 4 homolog Proteins 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 239000004215 Carbon black (E152) Substances 0.000 description 2
• 206010007275 Carcinoid tumour Diseases 0.000 description 2
• 102000055007 Cartilage Oligomeric Matrix Human genes 0.000 description 2
• 101710176668 Cartilage oligomeric matrix protein Proteins 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 201000005262 Chondroma Diseases 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 108010068192 Cyclin A Proteins 0.000 description 2
• 102000002428 Cyclin C Human genes 0.000 description 2
• 108010068155 Cyclin C Proteins 0.000 description 2
• 102100025191 Cyclin-A2 Human genes 0.000 description 2
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
• 102100022375 Dentin matrix acidic phosphoprotein 1 Human genes 0.000 description 2
• 101710105839 Dentin matrix acidic phosphoprotein 1 Proteins 0.000 description 2
• 208000008334 Dermatofibrosarcoma Diseases 0.000 description 2
• 206010057070 Dermatofibrosarcoma protuberans Diseases 0.000 description 2
• 102100035374 Dystrophia myotonica WD repeat-containing protein Human genes 0.000 description 2
• 208000034715 Enchondroma Diseases 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 208000010201 Exanthema Diseases 0.000 description 2
• 102000004864 Fibroblast growth factor 10 Human genes 0.000 description 2
• 108090001047 Fibroblast growth factor 10 Proteins 0.000 description 2
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 2
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 201000008808 Fibrosarcoma Diseases 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 2
• 229920002683 Glycosaminoglycan Polymers 0.000 description 2
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
• 208000001258 Hemangiosarcoma Diseases 0.000 description 2
• 208000032843 Hemorrhage Diseases 0.000 description 2
• 229920002971 Heparan sulfate Polymers 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000804521 Homo sapiens Dystrophia myotonica WD repeat-containing protein Proteins 0.000 description 2
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 2
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• 206010023825 Laryngeal cancer Diseases 0.000 description 2
• 208000018142 Leiomyosarcoma Diseases 0.000 description 2
• 102000029749 Microtubule Human genes 0.000 description 2
• 108091022875 Microtubule Proteins 0.000 description 2
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 2
• 208000008846 Neurocytoma Diseases 0.000 description 2
• 206010031096 Oropharyngeal cancer Diseases 0.000 description 2
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 2
• 208000000035 Osteochondroma Diseases 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 102000029797 Prion Human genes 0.000 description 2
• 108091000054 Prion Proteins 0.000 description 2
• 206010060862 Prostate cancer Diseases 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
• 108050002653 Retinoblastoma protein Proteins 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 108091027967 Small hairpin RNA Proteins 0.000 description 2
• 208000005718 Stomach Neoplasms Diseases 0.000 description 2
• 102000007000 Tenascin Human genes 0.000 description 2
• 108010008125 Tenascin Proteins 0.000 description 2
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 2
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 208000008383 Wilms tumor Diseases 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 208000009956 adenocarcinoma Diseases 0.000 description 2
• 210000004982 adipose tissue macrophage Anatomy 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 239000005557 antagonist Substances 0.000 description 2
• 238000009175 antibody therapy Methods 0.000 description 2
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
• 238000003782 apoptosis assay Methods 0.000 description 2
• 239000012298 atmosphere Substances 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 210000003651 basophil Anatomy 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000008236 biological pathway Effects 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 210000002449 bone cell Anatomy 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 150000001721 carbon Chemical group 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 208000002458 carcinoid tumor Diseases 0.000 description 2
• 210000003321 cartilage cell Anatomy 0.000 description 2
• 230000006369 cell cycle progression Effects 0.000 description 2
• 230000011712 cell development Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 210000002421 cell wall Anatomy 0.000 description 2
• 230000005754 cellular signaling Effects 0.000 description 2
• 208000025997 central nervous system neoplasm Diseases 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 208000006990 cholangiocarcinoma Diseases 0.000 description 2
• 201000010276 collecting duct carcinoma Diseases 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 239000007822 coupling agent Substances 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 239000000824 cytostatic agent Substances 0.000 description 2
• 230000001085 cytostatic effect Effects 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 210000004207 dermis Anatomy 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 230000003511 endothelial effect Effects 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 210000003979 eosinophil Anatomy 0.000 description 2
• 201000004101 esophageal cancer Diseases 0.000 description 2
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• 201000005884 exanthem Diseases 0.000 description 2
• 208000024519 eye neoplasm Diseases 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 210000000630 fibrocyte Anatomy 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 201000010175 gallbladder cancer Diseases 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 210000002175 goblet cell Anatomy 0.000 description 2
• 230000003394 haemopoietic effect Effects 0.000 description 2
• 230000035876 healing Effects 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 201000005787 hematologic cancer Diseases 0.000 description 2
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
• 230000013632 homeostatic process Effects 0.000 description 2
• 150000002430 hydrocarbons Chemical class 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 230000003463 hyperproliferative effect Effects 0.000 description 2
• 201000006866 hypopharynx cancer Diseases 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 206010023841 laryngeal neoplasm Diseases 0.000 description 2
• 210000000867 larynx Anatomy 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 210000002332 leydig cell Anatomy 0.000 description 2
• 208000010033 lipoblastoma Diseases 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 230000000527 lymphocytic effect Effects 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 230000036210 malignancy Effects 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 210000001161 mammalian embryo Anatomy 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 210000003593 megakaryocyte Anatomy 0.000 description 2
• 210000002752 melanocyte Anatomy 0.000 description 2
• 210000000716 merkel cell Anatomy 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 108091070501 miRNA Proteins 0.000 description 2
• 210000004688 microtubule Anatomy 0.000 description 2
• 230000000394 mitotic effect Effects 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 150000002772 monosaccharides Chemical group 0.000 description 2
• 210000000107 myocyte Anatomy 0.000 description 2
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 210000003928 nasal cavity Anatomy 0.000 description 2
• 230000009826 neoplastic cell growth Effects 0.000 description 2
• 210000000653 nervous system Anatomy 0.000 description 2
• 210000003757 neuroblast Anatomy 0.000 description 2
• 230000004766 neurogenesis Effects 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 201000006958 oropharynx cancer Diseases 0.000 description 2
• 230000026792 palmitoylation Effects 0.000 description 2
• 201000002528 pancreatic cancer Diseases 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 210000003695 paranasal sinus Anatomy 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 210000003800 pharynx Anatomy 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 210000000557 podocyte Anatomy 0.000 description 2
• 229920000570 polyether Polymers 0.000 description 2
• 230000017363 positive regulation of growth Effects 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 230000005522 programmed cell death Effects 0.000 description 2
• 210000002307 prostate Anatomy 0.000 description 2
• 125000006239 protecting group Chemical group 0.000 description 2
• 229940076372 protein antagonist Drugs 0.000 description 2
• 238000003156 radioimmunoprecipitation Methods 0.000 description 2
• 206010037844 rash Diseases 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 230000004491 retinal development Effects 0.000 description 2
• 210000001164 retinal progenitor cell Anatomy 0.000 description 2
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 210000000717 sertoli cell Anatomy 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 231100000046 skin rash Toxicity 0.000 description 2
• 208000000587 small cell lung carcinoma Diseases 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 201000002245 spindle cell lipoma Diseases 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 201000011549 stomach cancer Diseases 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 229920001059 synthetic polymer Polymers 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 235000008521 threonine Nutrition 0.000 description 2
• 210000001685 thyroid gland Anatomy 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 102000027257 transmembrane receptors Human genes 0.000 description 2
• 108091008578 transmembrane receptors Proteins 0.000 description 2
• 230000000472 traumatic effect Effects 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 102000003390 tumor necrosis factor Human genes 0.000 description 2
• 230000007306 turnover Effects 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 230000007998 vessel formation Effects 0.000 description 2
• 238000012800 visualization Methods 0.000 description 2
• JKHVDAUOODACDU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCN1C(=O)C=CC1=O JKHVDAUOODACDU-UHFFFAOYSA-N 0.000 description 1
• FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
• 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• 125000004398 2-methyl-2-butyl group Chemical group CC(C)(CC)* 0.000 description 1
• 125000004917 3-methyl-2-butyl group Chemical group CC(C(C)*)C 0.000 description 1
• 102100037263 3-phosphoinositide-dependent protein kinase 1 Human genes 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• NGGRGTWYSXYVDK-RRKCRQDMSA-N 4-amino-5-chloro-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound C1=C(Cl)C(N)=NC(=O)N1[C@@H]1O[C@H](CO)[C@@H](O)C1 NGGRGTWYSXYVDK-RRKCRQDMSA-N 0.000 description 1
• SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical group FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 206010057341 Adenolipoma Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 208000008884 Aneurysmal Bone Cysts Diseases 0.000 description 1
• 206010051810 Angiomyolipoma Diseases 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 102100026376 Artemin Human genes 0.000 description 1
• 206010064755 Atypical fibroxanthoma Diseases 0.000 description 1
• 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 description 1
• MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
• 206010004146 Basal cell carcinoma Diseases 0.000 description 1
• 206010004593 Bile duct cancer Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 102100028726 Bone morphogenetic protein 10 Human genes 0.000 description 1
• 102100028727 Bone morphogenetic protein 15 Human genes 0.000 description 1
• 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
• 102100022546 Bone morphogenetic protein 8A Human genes 0.000 description 1
• 102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 102100031746 Bone sialoprotein 2 Human genes 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 101150012716 CDK1 gene Proteins 0.000 description 1
• 229910014455 Ca-Cb Inorganic materials 0.000 description 1
• 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
• 201000000274 Carcinosarcoma Diseases 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102000004018 Caspase 6 Human genes 0.000 description 1
• 108090000425 Caspase 6 Proteins 0.000 description 1
• 102000004041 Caspase 7 Human genes 0.000 description 1
• 108090000567 Caspase 7 Proteins 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 208000005024 Castleman disease Diseases 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 206010007953 Central nervous system lymphoma Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241001432959 Chernes Species 0.000 description 1
• 208000010126 Chondromatosis Diseases 0.000 description 1
• 208000019591 Chondromyxoid fibroma Diseases 0.000 description 1
• 208000004139 Choroid Plexus Neoplasms Diseases 0.000 description 1
• 208000004378 Choroid plexus papilloma Diseases 0.000 description 1
• 208000037156 Choroid plexus tumor Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 206010009253 Clear cell sarcoma of the kidney Diseases 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 208000034656 Contusions Diseases 0.000 description 1
• 239000004971 Cross linker Substances 0.000 description 1
• 102000002427 Cyclin B Human genes 0.000 description 1
• 108010068150 Cyclin B Proteins 0.000 description 1
• 102000003909 Cyclin E Human genes 0.000 description 1
• 108090000257 Cyclin E Proteins 0.000 description 1
• 108010068237 Cyclin H Proteins 0.000 description 1
• 108010068106 Cyclin T Proteins 0.000 description 1
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
• 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
• 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
• 102100036883 Cyclin-H Human genes 0.000 description 1
• 102100036876 Cyclin-K Human genes 0.000 description 1
• 102100024109 Cyclin-T1 Human genes 0.000 description 1
• 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 1
• 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 1
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
• 102100026865 Cyclin-dependent kinase 5 activator 1 Human genes 0.000 description 1
• 102100026855 Cyclin-dependent kinase 5 activator 2 Human genes 0.000 description 1
• 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
• 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 1
• 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 1
• 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102000004237 Decorin Human genes 0.000 description 1
• 108090000738 Decorin Proteins 0.000 description 1
• 208000005156 Dehydration Diseases 0.000 description 1
• 102100040897 Embryonic growth/differentiation factor 1 Human genes 0.000 description 1
• 208000000088 Enchondromatosis Diseases 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 206010014970 Ephelides Diseases 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 208000012468 Ewing sarcoma/peripheral primitive neuroectodermal tumor Diseases 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 description 1
• 101150021185 FGF gene Proteins 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 102000017177 Fibromodulin Human genes 0.000 description 1
• 108010013996 Fibromodulin Proteins 0.000 description 1
• 208000008961 Fibrous Dysplasia of Bone Diseases 0.000 description 1
• 210000000712 G cell Anatomy 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 101000950677 Gallus gallus Myosin light chain 1, skeletal muscle isoform Proteins 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 208000031852 Gastrointestinal stromal cancer Diseases 0.000 description 1
• 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
• 208000002966 Giant Cell Tumor of Bone Diseases 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
• 201000005409 Gliomatosis cerebri Diseases 0.000 description 1
• 206010068601 Glioneuronal tumour Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 1
• 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 1
• 102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
• 102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
• 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
• 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 1
• 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
• 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
• 108050006583 Growth/differentiation factor 8 Proteins 0.000 description 1
• 102100035970 Growth/differentiation factor 9 Human genes 0.000 description 1
• 208000006050 Hemangiopericytoma Diseases 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
• 101000785776 Homo sapiens Artemin Proteins 0.000 description 1
• 101000695367 Homo sapiens Bone morphogenetic protein 10 Proteins 0.000 description 1
• 101000695360 Homo sapiens Bone morphogenetic protein 15 Proteins 0.000 description 1
• 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
• 101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 1
• 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 1
• 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
• 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 1
• 101000899364 Homo sapiens Bone morphogenetic protein 8A Proteins 0.000 description 1
• 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
• 101000707248 Homo sapiens Bone sialoprotein 2 Proteins 0.000 description 1
• 101000713127 Homo sapiens Cyclin-K Proteins 0.000 description 1
• 101000912115 Homo sapiens Cyclin-dependent kinase 5 activator 2 Proteins 0.000 description 1
• 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 1
• 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 1
• 101000893552 Homo sapiens Embryonic growth/differentiation factor 1 Proteins 0.000 description 1
• 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 1
• 101000893545 Homo sapiens Growth/differentiation factor 11 Proteins 0.000 description 1
• 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
• 101000893585 Homo sapiens Growth/differentiation factor 2 Proteins 0.000 description 1
• 101001023986 Homo sapiens Growth/differentiation factor 3 Proteins 0.000 description 1
• 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
• 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
• 101001023968 Homo sapiens Growth/differentiation factor 7 Proteins 0.000 description 1
• 101000886562 Homo sapiens Growth/differentiation factor 8 Proteins 0.000 description 1
• 101001075110 Homo sapiens Growth/differentiation factor 9 Proteins 0.000 description 1
• 101001076604 Homo sapiens Inhibin alpha chain Proteins 0.000 description 1
• 101001054725 Homo sapiens Inhibin beta B chain Proteins 0.000 description 1
• 101001054832 Homo sapiens Inhibin beta C chain Proteins 0.000 description 1
• 101001054830 Homo sapiens Inhibin beta E chain Proteins 0.000 description 1
• 101000967920 Homo sapiens Left-right determination factor 1 Proteins 0.000 description 1
• 101000967918 Homo sapiens Left-right determination factor 2 Proteins 0.000 description 1
• 101000984626 Homo sapiens Low-density lipoprotein receptor-related protein 12 Proteins 0.000 description 1
• 101000635885 Homo sapiens Myosin light chain 1/3, skeletal muscle isoform Proteins 0.000 description 1
• 101100241084 Homo sapiens NRTN gene Proteins 0.000 description 1
• 101001136670 Homo sapiens Persephin Proteins 0.000 description 1
• 101000769159 Homo sapiens Protein yippee-like 3 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101000661807 Homo sapiens Suppressor of tumorigenicity 14 protein Proteins 0.000 description 1
• 101000701411 Homo sapiens Suppressor of tumorigenicity 7 protein Proteins 0.000 description 1
• 101000635958 Homo sapiens Transforming growth factor beta-2 proprotein Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
• 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
• 230000006133 ISGylation Effects 0.000 description 1
• 101150002416 Igf2 gene Proteins 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 102100025885 Inhibin alpha chain Human genes 0.000 description 1
• 102100027004 Inhibin beta A chain Human genes 0.000 description 1
• 102100027003 Inhibin beta B chain Human genes 0.000 description 1
• 102100026812 Inhibin beta C chain Human genes 0.000 description 1
• 102100026818 Inhibin beta E chain Human genes 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
• 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
• 206010023347 Keratoacanthoma Diseases 0.000 description 1
• 229930194542 Keto Chemical class 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 102000010638 Kinesin Human genes 0.000 description 1
• 108010063296 Kinesin Proteins 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• ZFOMKMMPBOQKMC-KXUCPTDWSA-N L-pyrrolysine Chemical compound C[C@@H]1CC=N[C@H]1C(=O)NCCCC[C@H]([NH3+])C([O-])=O ZFOMKMMPBOQKMC-KXUCPTDWSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 239000005517 L01XE01 - Imatinib Substances 0.000 description 1
• 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
• 239000005551 L01XE03 - Erlotinib Substances 0.000 description 1
• 239000002147 L01XE04 - Sunitinib Substances 0.000 description 1
• 239000005511 L01XE05 - Sorafenib Substances 0.000 description 1
• UCEQXRCJXIVODC-PMACEKPBSA-N LSM-1131 Chemical compound C1CCC2=CC=CC3=C2N1C=C3[C@@H]1C(=O)NC(=O)[C@H]1C1=CNC2=CC=CC=C12 UCEQXRCJXIVODC-PMACEKPBSA-N 0.000 description 1
• 102100040508 Left-right determination factor 1 Human genes 0.000 description 1
• 102100040511 Left-right determination factor 2 Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100032114 Lumican Human genes 0.000 description 1
• 108010076371 Lumican Proteins 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 201000003791 MALT lymphoma Diseases 0.000 description 1
• 102000043136 MAP kinase family Human genes 0.000 description 1
• 108091054455 MAP kinase family Proteins 0.000 description 1
• 206010073087 Malignant sweat gland neoplasm Diseases 0.000 description 1
• 208000032271 Malignant tumor of penis Diseases 0.000 description 1
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
• 201000001853 McCune-Albright syndrome Diseases 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 208000003351 Melanosis Diseases 0.000 description 1
• 208000007650 Meningeal Carcinomatosis Diseases 0.000 description 1
• 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
• 201000009574 Mesenchymal Chondrosarcoma Diseases 0.000 description 1
• 206010070665 Mesoblastic nephroma Diseases 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 206010051696 Metastases to meninges Diseases 0.000 description 1
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
• 208000003445 Mouth Neoplasms Diseases 0.000 description 1
• 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 1
• 101710122877 Muellerian-inhibiting factor Proteins 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 101100096242 Mus musculus Sox9 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 102100030740 Myosin light chain 1/3, skeletal muscle isoform Human genes 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
• 102100021584 Neurturin Human genes 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 208000026616 Ollier disease Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 208000001715 Osteoblastoma Diseases 0.000 description 1
• 208000006024 Osteochondromatosis Diseases 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000025618 Paget disease of nipple Diseases 0.000 description 1
• 208000037064 Papilloma of choroid plexus Diseases 0.000 description 1
• 102000018546 Paxillin Human genes 0.000 description 1
• ACNHBCIZLNNLRS-UHFFFAOYSA-N Paxilline 1 Natural products N1C2=CC=CC=C2C2=C1C1(C)C3(C)CCC4OC(C(C)(O)C)C(=O)C=C4C3(O)CCC1C2 ACNHBCIZLNNLRS-UHFFFAOYSA-N 0.000 description 1
• 208000002471 Penile Neoplasms Diseases 0.000 description 1
• 206010034299 Penile cancer Diseases 0.000 description 1
• 102100036660 Persephin Human genes 0.000 description 1
• 201000007286 Pilocytic astrocytoma Diseases 0.000 description 1
• 206010050487 Pinealoblastoma Diseases 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 201000007288 Pleomorphic xanthoastrocytoma Diseases 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004721 Polyphenylene oxide Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 208000004965 Prostatic Intraepithelial Neoplasia Diseases 0.000 description 1
• 206010071019 Prostatic dysplasia Diseases 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102100028368 Protein yippee-like 3 Human genes 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000001190 Q-PCR Methods 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 102100038042 Retinoblastoma-associated protein Human genes 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 201000001718 Roberts syndrome Diseases 0.000 description 1
• 208000012474 Roberts-SC phocomelia syndrome Diseases 0.000 description 1
• 230000006295 S-nitrosylation Effects 0.000 description 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 241000605112 Scapanulus oweni Species 0.000 description 1
• 102100034201 Sclerostin Human genes 0.000 description 1
• 108050006698 Sclerostin Proteins 0.000 description 1
• 208000032383 Soft tissue cancer Diseases 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 208000001662 Subependymal Glioma Diseases 0.000 description 1
• 108090000058 Syndecan-1 Proteins 0.000 description 1
• 102100026087 Syndecan-2 Human genes 0.000 description 1
• 108090000054 Syndecan-2 Proteins 0.000 description 1
• 102100026084 Syndecan-3 Human genes 0.000 description 1
• 108090000068 Syndecan-3 Proteins 0.000 description 1
• 102100037220 Syndecan-4 Human genes 0.000 description 1
• 108010055215 Syndecan-4 Proteins 0.000 description 1
• 206010043276 Teratoma Diseases 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 108700031954 Tgfb1i1/Leupaxin/TGFB1I1 Proteins 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 208000000728 Thymus Neoplasms Diseases 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102100030737 Transforming growth factor beta-2 proprotein Human genes 0.000 description 1
• 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
• 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 239000006035 Tryptophane Substances 0.000 description 1
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 238000005411 Van der Waals force Methods 0.000 description 1
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 1
• 102000013127 Vimentin Human genes 0.000 description 1
• 108010065472 Vimentin Proteins 0.000 description 1
• 102000003970 Vinculin Human genes 0.000 description 1
• 108090000384 Vinculin Proteins 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 208000016025 Waldenstroem macroglobulinemia Diseases 0.000 description 1
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
• 230000009102 absorption Effects 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 230000006154 adenylylation Effects 0.000 description 1
• 201000005188 adrenal gland cancer Diseases 0.000 description 1
• 208000024447 adrenal gland neoplasm Diseases 0.000 description 1
• 210000002945 adventitial reticular cell Anatomy 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 210000004712 air sac Anatomy 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 210000002383 alveolar type I cell Anatomy 0.000 description 1
• 210000002588 alveolar type II cell Anatomy 0.000 description 1
• 229950010817 alvocidib Drugs 0.000 description 1
• BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical compound O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 206010002224 anaplastic astrocytoma Diseases 0.000 description 1
• 239000002870 angiogenesis inducing agent Substances 0.000 description 1
• 208000009887 angiolipoma Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 210000000436 anus Anatomy 0.000 description 1
• 201000011165 anus cancer Diseases 0.000 description 1
• 210000000709 aorta Anatomy 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 210000004396 apud cell Anatomy 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000010516 arginylation Effects 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000017047 asymmetric cell division Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 229960000397 bevacizumab Drugs 0.000 description 1
• 208000026900 bile duct neoplasm Diseases 0.000 description 1
• 230000001851 biosynthetic effect Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 150000001615 biotins Chemical class 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 208000034158 bleeding Diseases 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 201000011143 bone giant cell tumor Diseases 0.000 description 1
• 230000010478 bone regeneration Effects 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 210000000233 bronchiolar non-ciliated Anatomy 0.000 description 1
• 230000006242 butyrylation Effects 0.000 description 1
• 238000010514 butyrylation reaction Methods 0.000 description 1
• 230000009702 cancer cell proliferation Effects 0.000 description 1
• 230000009400 cancer invasion Effects 0.000 description 1
• 208000035269 cancer or benign tumor Diseases 0.000 description 1
• 230000021235 carbamoylation Effects 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 231100000357 carcinogen Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000018486 cell cycle phase Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000004640 cellular pathway Effects 0.000 description 1
• 201000010702 central neurocytoma Diseases 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 208000015632 childhood ependymoma Diseases 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 201000005217 chondroblastoma Diseases 0.000 description 1
• 230000009816 chondrogenic differentiation Effects 0.000 description 1
• 230000002648 chondrogenic effect Effects 0.000 description 1
• 201000001902 chondroid lipoma Diseases 0.000 description 1
• 208000006571 choroid plexus carcinoma Diseases 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 201000010902 chronic myelomonocytic leukemia Diseases 0.000 description 1
• 210000000189 circulating neoplastic cell Anatomy 0.000 description 1
• 230000006329 citrullination Effects 0.000 description 1
• 229950006647 cixutumumab Drugs 0.000 description 1
• 208000009060 clear cell adenocarcinoma Diseases 0.000 description 1
• 208000030748 clear cell sarcoma of kidney Diseases 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 229940096422 collagen type i Drugs 0.000 description 1
• 210000002777 columnar cell Anatomy 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000006854 communication Effects 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000004154 complement system Effects 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000011254 conventional chemotherapy Methods 0.000 description 1
• 238000011443 conventional therapy Methods 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 201000004669 corpus callosum lipoma Diseases 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 238000002447 crystallographic data Methods 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000002498 deadly effect Effects 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 230000007783 downstream signaling Effects 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 201000004428 dysembryoplastic neuroepithelial tumor Diseases 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 230000009881 electrostatic interaction Effects 0.000 description 1
• 230000006330 eliminylation Effects 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 210000003158 enteroendocrine cell Anatomy 0.000 description 1
• 208000023437 ependymal tumor Diseases 0.000 description 1
• 210000002336 epiblast cell Anatomy 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 229940082789 erbitux Drugs 0.000 description 1
• 229960001433 erlotinib Drugs 0.000 description 1
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 229960005167 everolimus Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 201000005930 extraskeletal chondroma Diseases 0.000 description 1
• 210000004700 fetal blood Anatomy 0.000 description 1
• 201000001169 fibrillary astrocytoma Diseases 0.000 description 1
• 230000003328 fibroblastic effect Effects 0.000 description 1
• 201000010103 fibrous dysplasia Diseases 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 201000008361 ganglioneuroma Diseases 0.000 description 1
• 230000007045 gastrulation Effects 0.000 description 1
• 229960002584 gefitinib Drugs 0.000 description 1
• XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 238000012226 gene silencing method Methods 0.000 description 1
• 238000012637 gene transfection Methods 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 231100000722 genetic damage Toxicity 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 210000001654 germ layer Anatomy 0.000 description 1
• 208000003884 gestational trophoblastic disease Diseases 0.000 description 1
• 201000011610 giant cell glioblastoma Diseases 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 230000004022 gliogenesis Effects 0.000 description 1
• 208000002409 gliosarcoma Diseases 0.000 description 1
• 102000034238 globular proteins Human genes 0.000 description 1
• 108091005896 globular proteins Proteins 0.000 description 1
• 210000001282 glomerular podocyte Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 230000006237 glutamylation Effects 0.000 description 1
• 230000035430 glutathionylation Effects 0.000 description 1
• 230000036252 glycation Effects 0.000 description 1
• 230000006095 glypiation Effects 0.000 description 1
• 229920000578 graft copolymer Polymers 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 210000004024 hepatic stellate cell Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 210000000514 hepatopancreas Anatomy 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 210000003035 hyaline cartilage Anatomy 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
• 125000001183 hydrocarbyl group Chemical group 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 1
• 229960002411 imatinib Drugs 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 230000000899 immune system response Effects 0.000 description 1
• 238000003125 immunofluorescent labeling Methods 0.000 description 1
• 208000025095 immunoproliferative disease Diseases 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 231100000405 induce cancer Toxicity 0.000 description 1
• 201000011489 infantile myofibromatosis Diseases 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 108010019691 inhibin beta A subunit Proteins 0.000 description 1
• 230000000266 injurious effect Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000008611 intercellular interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 201000000934 internal auditory canal lipoma Diseases 0.000 description 1
• 210000002570 interstitial cell Anatomy 0.000 description 1
• 210000004495 interstitial cells of cajal Anatomy 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 201000010151 inverted papilloma Diseases 0.000 description 1
• 229940110676 inzo Drugs 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000006122 isoprenylation Effects 0.000 description 1
• 230000000366 juvenile effect Effects 0.000 description 1
• 125000000468 ketone group Chemical class 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 208000024596 kidney oncocytoma Diseases 0.000 description 1
• 210000001865 kupffer cell Anatomy 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 210000005246 left atrium Anatomy 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 230000006144 lipoylation Effects 0.000 description 1
• 238000009630 liquid culture Methods 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 208000012804 lymphangiosarcoma Diseases 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 210000001365 lymphatic vessel Anatomy 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 208000006178 malignant mesothelioma Diseases 0.000 description 1
• 201000000281 malignant syringoma Diseases 0.000 description 1
• 208000025848 malignant tumor of nasopharynx Diseases 0.000 description 1
• 230000017538 malonylation Effects 0.000 description 1
• 210000004997 mammalian reproductive system Anatomy 0.000 description 1
• 208000027202 mammary Paget disease Diseases 0.000 description 1
• 238000013160 medical therapy Methods 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 201000008203 medulloepithelioma Diseases 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 210000003584 mesangial cell Anatomy 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 210000004115 mitral valve Anatomy 0.000 description 1
• 208000022951 mixed epithelial stromal tumor Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 108091005601 modified peptides Proteins 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• 238000012900 molecular simulation Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 230000036457 multidrug resistance Effects 0.000 description 1
• 210000001074 muscle attachment cell Anatomy 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 210000001167 myeloblast Anatomy 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 230000001114 myogenic effect Effects 0.000 description 1
• 210000001087 myotubule Anatomy 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• 201000009500 myxoid chondrosarcoma Diseases 0.000 description 1
• LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 208000018795 nasal cavity and paranasal sinus carcinoma Diseases 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000009527 neddylation Effects 0.000 description 1
• 230000017066 negative regulation of growth Effects 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000000276 neural tube Anatomy 0.000 description 1
• 208000027831 neuroepithelial neoplasm Diseases 0.000 description 1
• 108010064131 neuronal Cdk5 activator (p25-p35) Proteins 0.000 description 1
• 102000045246 noggin Human genes 0.000 description 1
• 108700007229 noggin Proteins 0.000 description 1
• 230000000683 nonmetastatic effect Effects 0.000 description 1
• 210000003458 notochord Anatomy 0.000 description 1
• 230000005257 nucleotidylation Effects 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 206010073131 oligoastrocytoma Diseases 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 108091008819 oncoproteins Proteins 0.000 description 1
• 201000011130 optic nerve sheath meningioma Diseases 0.000 description 1
• 201000005443 oral cavity cancer Diseases 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000011164 ossification Effects 0.000 description 1
• 208000003388 osteoid osteoma Diseases 0.000 description 1
• 208000008798 osteoma Diseases 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 210000001711 oxyntic cell Anatomy 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 210000002705 pancreatic stellate cell Anatomy 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• ACNHBCIZLNNLRS-UBGQALKQSA-N paxilline Chemical compound N1C2=CC=CC=C2C2=C1[C@]1(C)[C@@]3(C)CC[C@@H]4O[C@H](C(C)(O)C)C(=O)C=C4[C@]3(O)CC[C@H]1C2 ACNHBCIZLNNLRS-UBGQALKQSA-N 0.000 description 1
• 201000000389 pediatric ependymoma Diseases 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
• 150000002972 pentoses Chemical class 0.000 description 1
• 230000009984 peri-natal effect Effects 0.000 description 1
• 210000003668 pericyte Anatomy 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000005261 phosphopantetheinylation Effects 0.000 description 1
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
• 108091008695 photoreceptors Proteins 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 206010035059 pineocytoma Diseases 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 229920000962 poly(amidoamine) Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 230000001884 polyglutamylation Effects 0.000 description 1
• 230000019474 polyglycylation Effects 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 230000006267 polysialylation Effects 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 238000003822 preparative gas chromatography Methods 0.000 description 1
• 208000016800 primary central nervous system lymphoma Diseases 0.000 description 1
• 208000029340 primitive neuroectodermal tumor Diseases 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000031877 prophase Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 230000006289 propionylation Effects 0.000 description 1
• 238000010515 propionylation reaction Methods 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 208000021046 prostate intraepithelial neoplasia Diseases 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 210000003492 pulmonary vein Anatomy 0.000 description 1
• 230000017614 pupylation Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
• 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000022983 regulation of cell cycle Effects 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 208000005039 renal oncocytoma Diseases 0.000 description 1
• 230000001718 repressive effect Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• OAKGNIRUXAZDQF-TXHRRWQRSA-N retaspimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(O)C1=CC(O)=C2NCC=C OAKGNIRUXAZDQF-TXHRRWQRSA-N 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 239000002342 ribonucleoside Substances 0.000 description 1
• 238000005001 rutherford backscattering spectroscopy Methods 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 229950009919 saracatinib Drugs 0.000 description 1
• OUKYUETWWIPKQR-UHFFFAOYSA-N saracatinib Chemical compound C1CN(C)CCN1CCOC1=CC(OC2CCOCC2)=C(C(NC=2C(=CC=C3OCOC3=2)Cl)=NC=N2)C2=C1 OUKYUETWWIPKQR-UHFFFAOYSA-N 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 210000004761 scalp Anatomy 0.000 description 1
• 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
• 201000007321 sebaceous carcinoma Diseases 0.000 description 1
• 208000011571 secondary malignant neoplasm Diseases 0.000 description 1
• 208000011581 secondary neoplasm Diseases 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 235000016491 selenocysteine Nutrition 0.000 description 1
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
• 229940055619 selenocysteine Drugs 0.000 description 1
• WUWDLXZGHZSWQZ-WQLSENKSSA-N semaxanib Chemical compound N1C(C)=CC(C)=C1\C=C/1C2=CC=CC=C2NC\1=O WUWDLXZGHZSWQZ-WQLSENKSSA-N 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 150000003354 serine derivatives Chemical class 0.000 description 1
• 150000003355 serines Chemical class 0.000 description 1
• 230000014639 sexual reproduction Effects 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 230000008491 skin homeostasis Effects 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 208000019791 soft tissue chondroma Diseases 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 210000001988 somatic stem cell Anatomy 0.000 description 1
• 210000002325 somatostatin-secreting cell Anatomy 0.000 description 1
• 229960003787 sorafenib Drugs 0.000 description 1
• OJLGASCOGOIOJR-UHFFFAOYSA-N soyasaponin gammag Natural products CC1=C(O)C(=O)CC(OC2CC(C)(C)CC3C4=CCC5C6(C)CCC(OC7OC(C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(=O)O)C(C)(CO)C6CCC5(C)C4(C)CCC23C)O1 OJLGASCOGOIOJR-UHFFFAOYSA-N 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 208000028647 spindle cell neoplasm Diseases 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 102000009076 src-Family Kinases Human genes 0.000 description 1
• 108010087686 src-Family Kinases Proteins 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 210000000603 stem cell niche Anatomy 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 201000004059 subependymal giant cell astrocytoma Diseases 0.000 description 1
• 208000030819 subependymoma Diseases 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 230000035322 succinylation Effects 0.000 description 1
• 238000010613 succinylation reaction Methods 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 230000010741 sumoylation Effects 0.000 description 1
• WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
• 229960001796 sunitinib Drugs 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 210000004876 tela submucosa Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 150000007970 thio esters Chemical class 0.000 description 1
• 150000003588 threonines Chemical class 0.000 description 1
• 201000009377 thymus cancer Diseases 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• PLHJCIYEEKOWNM-HHHXNRCGSA-N tipifarnib Chemical compound CN1C=NC=C1[C@](N)(C=1C=C2C(C=3C=C(Cl)C=CC=3)=CC(=O)N(C)C2=CC=1)C1=CC=C(Cl)C=C1 PLHJCIYEEKOWNM-HHHXNRCGSA-N 0.000 description 1
• 229950009158 tipifarnib Drugs 0.000 description 1
• 230000030968 tissue homeostasis Effects 0.000 description 1
• 229950005976 tivantinib Drugs 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 206010044412 transitional cell carcinoma Diseases 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 229960000575 trastuzumab Drugs 0.000 description 1
• 201000008945 trilateral retinoblastoma Diseases 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 210000004926 tubular epithelial cell Anatomy 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 208000037965 uterine sarcoma Diseases 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 1
• 230000004218 vascular function Effects 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 210000005048 vimentin Anatomy 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 102100035070 von Hippel-Lindau disease tumor suppressor Human genes 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• 210000001325 yolk sac Anatomy 0.000 description 1